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CDC HEALTH ADVISORY
CDC Recommends Suspension of the Routine use of the Third and Fourth 
Doses of Pneumococcal Conjugate Vaccine (Prevnar®)
All health-care providers should temporarily suspend routine use of both the third and fourth doses of 
pneumococcal conjugate vaccine (PCV7), the Centers for Disease Control and Prevention (CDC) recommended 
today. Children at increased risk of severe disease should continue to receive the full, routine, four-dose series.
CDC took the action in consultation with the American Academy of Family Physicians (AAFP), the American 
Academy of Pediatrics (AAP), and the Advisory Committee on Immunization Practices (ACIP), to most effectively 
use the limited, available doses of until the manufacturer can restore full production. Wyeth Vaccines, the sole 
manufacturer in the United States, markets PCV7 under the trade name Prevnar®.
“ CDC is concerned anytime children are not able to receive all of the recommended doses of a recommended 
vaccine,” said Dr. Steve Cochi, acting director for the CDC's National Immunization Program. “ Delaying the third 
and fourth doses of this important vaccine is not ideal; however, it is important to take steps to assure all children 
receive some protection with at least two doses of vaccines.”
CDC had previously recommended that health-care providers temporarily suspend routine use the fourth dose. 
Since that recommendation was issued, PCV7 production has been much less than had been expected and 
shipments have been further delayed, resulting in shortages of vaccine. Widespread shortages may now continue 
beyond this summer.
“ Four doses of PCV7 provide the best protection, but children who have received three doses should also have a 
very high level of protection,” said Dr. Cochi. “ Children who have had two doses should also have some 
protection, but the exact level is unknown.”
Children whose third and fourth doses are delayed should receive the missed doses on their first visit to a 
healthcare provider after supplies return to normal. Healthcare providers should keep track of children who are 
not able to get all of the recommended doses of the vaccine and then contact those patients when they receive 
adequate supplies of vaccine.
Children with certain health conditions, such as sickle cell anemia or immune system disorders, are at increased 
risk of severe disease and should continue to receive the full, routine, four-dose series.
The vaccine is normally recommended for young children in a four-dose schedule: one dose at 2 months, at 4 
months, and at 6 months, and one dose between 12 and 15 months. This recommendation suspends the third 
and fourth doses usually administered at 6 months and between 12 and 15 months for healthy children. PCV7 is 
not routinely recommended for children 2 years of age or older.
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The vaccine can help prevent serious pneumococcal diseases, such as meningitis and blood infections. 
Pneumococcal infection can cause serious illness and even death. Invasive pneumococcal disease is the leading 
cause of bacterial meningitis in the United States. Children under two years of age are at highest risk. Before a 
vaccine was available, each year pneumococcal infection caused more than 700 cases of meningitis, 13,000 
blood infections and about 5 million ear infections.
W H Y  Y O U R  CHILD MAY H A V E  TO W A IT  TO G E T  H IS  O R  H E R  TH IRD  O R  F O U R T H  D O S E  
OF P R E V N A R ® V A C C IN E :  F A C T S  F O R  P A R E N T S
• At this time, there is a low supply of pneumococcal conjugate vaccine, also called Prevnar®. This vaccine
protects children against serious disease and death caused by bacteria called Streptococcus pneumoniae.
• Because of low supplies, it is important to take steps to make sure all children get some Prevnar® vaccinations.
• While supplies are low, your healthcare provider has been asked to wait to give most children their 3rd and 4th
doses of Prevnar® vaccine. Children whose 3rd or 4th dose is delayed should receive it on their first doctor's visit 
after supplies return to normal.
• Four doses of Prevnar® vaccine provide the best protection, but your child will still have a very high level of
protection if he or she has had three doses. Children who have had two doses of Prevnar® should also have 
some protection, but the exact level is not known.
• Children with certain health conditions, like sickle cell anemia or immune system disorders, are more prone to
Streptococcus pneumoniae infections. Such children should still get all four shots.
• By temporarily not giving the third and fourth doses of Prevnar® vaccine to healthy children, healthcare providers
will save many doses of vaccine. As a result, there should be enough vaccine for all children to get at least 
two doses.
• Experts do not know exactly when supplies of Prevnar® vaccine will be back to normal. They expect supplies to
be limited for several more months.
More Information
Vaccinating your children is one of the most important ways you can protect them from infectious diseases. 
Children should get certain vaccines when they reach certain ages, according to the recommended immunization 
schedule. Vaccinating children on time helps to give them the best protection possible.
Prevnar® is one of the vaccines in the recommended childhood immunization schedule. This vaccine protects 
against disease caused by bacteria called Streptococcus pneumoniae. This bacteria can cause serious illness, 
including meningitis (an infection of the covering of the brain), blood stream infections, and infection of the lungs. 
Streptococcus pneumoniae can infect anyone, but is most likely to cause serious infection in infants and in 
children with certain medical conditions. Infants and toddlers should usually get four doses of Prevnar®, one dose 
at 2 months, 4 months, 6 months, and 12-15 months of age.
Once in a while in the U.S., we do not have enough vaccine to vaccinate all children on time. When this happens, 
doctors may need to make temporary changes in their patient's vaccination
schedules. This is done to help save vaccines and ensure that the children most in need of protection get it. In 
February 2004, doctors and other experts became worried that the supply of Prevnar® would be low for several 
months.
Steps have been taken by the vaccine manufacturer and the Centers for Disease Control and Prevention (CDC) 
in an attempt to prevent healthcare providers from running out of Prevnar® vaccine. These steps have worked so 
far, but more needs to be done.
CDC, the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) have 
decided to recommend that doctors continue to give all children the first two doses of Prevnar® vaccine but that 
they stop, for now, giving healthy children the third and fourth doses scheduled to be given at 6 months and 12-15 
months of age.
Delaying the third and fourth doses of Prevnar® is not ideal. However, this step will help make sure that all children 
get at least two doses of the vaccine. Doctors and other experts believe that giving all children two vaccinations 
will result in less disease than if some children get 3 or 4 doses while others get none.
Children with certain health conditions that make them more prone to Streptococcus pneumoniae infections 
should still get all four shots. Your healthcare provider can help determine if your child has a health condition that 
puts him or her at increased risk.
If we did not delay the 3rd and 4th doses of Prevnar® for most children, there would probably be widespread, serious 
shortages. If this happened, some children might not get any doses of the vaccine. By not giving the third and 
fourth doses routinely, we expect to save a large amount of vaccine so that all children will be protected with at 
least two doses.
CDC, AAP, and AAFP continue to watch the vaccine supply situation closely. No other routine childhood vaccines 
are in short supply so your child should continue to receive all the other vaccines on the normal schedule. More 
information about vaccine shortages is available at www.cdc.gov/nip/news/shortages. Information about what 
vaccines your child should receive can be found at www.cdc.gov/nip/kidstuff.
For more information, visit www.cdc.gov/nip, or call the CDC National Immunization Information Hotline (800)
232-2522 (English), (800) 232-0233 (Español), or (800) 243-7889 (TTY)
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national and international
organizations.
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